By Sheeba M. | May 23, 2026
Same-Store Sales Deceleration: The Hidden Margin Killer in Q2 Comps
Wall Street is bracing for earnings disappointments, but most analysts are looking at the wrong metric. It’s not about revenue beats or misses—it’s about what happens to margins when comp-store sales decelerate.
The SSS Deceleration
Based on transaction data from state regulatory filings and third-party retail trackers, cannabis retailers are seeing same-store sales growth slide into single digits for the first time since Q2 2023. Trulieve stores in Florida and California are running 5-6% comps. Curaleaf in Arizona is flat.
The drivers are familiar but accelerating:
- Inventory normalization: Wholesale cannabis prices fell 18% nationally since March. Retailers are holding inventory longer, waiting for better turns.
- Price elasticity: Consumers are trading down to lower-margin flower products. Premium pre-rolls and edibles (60%+ margins) are taking share loss to budget flower (35% margins).
- State saturation: New licenses in CA, CO, and IL are fragmenting market share. America’s Green Company is feeling this most acutely in Illinois.
The Margin Cascade
SSS deceleration becomes a margin crisis when retailers can’t reduce operating expenses fast enough. Rent, labor, and compliance costs are sticky. If Trulieve can’t grow revenue per square foot, gross margin compression is inevitable.
Here’s what to watch: Do MSOs aggressively shut underperforming stores in Q2, or do they keep them open hoping for recovery? Verano‘s Q1 guidance cut looked like a SSS miss in disguise. Expect similar language from others in their Q2 calls.
Green Thumb Industries has historically managed SSS deceleration better than peers by focusing on high-margin products. Watch their June call for strategic shifts towards edibles and concentrates.
Sources
- Cannabis News Network — Retail transaction tracking
- BDSA Analytics — Wholesale pricing data
- SEC Filings — Company guidance revisions
Track cannabis stocks with the Weedstock Real-Time Tracker